Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Steven Y. Hua Gregor Verhoef Luis E. Fayad Peter Johnson Mitchell Smith |
| Publication date | January 7, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |